Skip to content
10-K

Annual Report

Nabriva Therapeutics plc

0001558370-23-006062

← back to feed
Filed
Apr 17, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Feb 28, 2023 3.2M sh
Shares Diluted FY 2022 · Dec 31, 2022 2.68M sh
Shares Diluted restated FY 2022 · Dec 31, 2021 1.73M sh
Shares Diluted restated FY 2022 · Dec 31, 2020 513.8K sh
Capex FY 2022 · Dec 31, 2022 $211K
Capex FY 2022 · Dec 31, 2021 $25K
Capex FY 2022 · Dec 31, 2020 $113K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$36.71M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$59.56M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$71.33M
Long Term Debt FY 2022 · Dec 31, 2022 $388K
Long Term Debt FY 2022 · Dec 31, 2021 $4.27M
Short Term Debt FY 2022 · Dec 31, 2022 $4.83M
Short Term Debt FY 2022 · Dec 31, 2021 $3.77M
Cash And Equivalents FY 2022 · Dec 31, 2022 $12.41M
Cash And Equivalents FY 2022 · Dec 31, 2021 $47.66M
Stockholders Equity FY 2022 · Dec 31, 2022 $3.29M
Stockholders Equity FY 2022 · Dec 31, 2021 $53.35M
Stockholders Equity FY 2022 · Dec 31, 2020 $33.14M
Stockholders Equity FY 2022 · Dec 31, 2019 $41.27M
Current Liabilities FY 2022 · Dec 31, 2022 $27.61M
Current Liabilities FY 2022 · Dec 31, 2021 $22.34M
Total Liabilities FY 2022 · Dec 31, 2022 $28.47M
Total Liabilities FY 2022 · Dec 31, 2021 $27.56M
Current Assets FY 2022 · Dec 31, 2022 $31.1M
Current Assets FY 2022 · Dec 31, 2021 $80.27M
Total Assets FY 2022 · Dec 31, 2022 $31.77M
Total Assets FY 2022 · Dec 31, 2021 $80.91M
Eps Diluted FY 2022 · Dec 31, 2022 −$21.32
Eps Diluted restated FY 2022 · Dec 31, 2021 −$28.52
Eps Diluted restated FY 2022 · Dec 31, 2020 −$135.23
Eps Basic FY 2022 · Dec 31, 2022 −$21.32
Eps Basic restated FY 2022 · Dec 31, 2021 −$28.52
Eps Basic restated FY 2022 · Dec 31, 2020 −$135.23
Sga Expense FY 2022 · Dec 31, 2022 $45.26M
Sga Expense FY 2022 · Dec 31, 2021 $51.65M
Sga Expense FY 2022 · Dec 31, 2020 $55.29M
Rd Expense FY 2022 · Dec 31, 2022 $14.26M
Rd Expense FY 2022 · Dec 31, 2021 $12.63M
Rd Expense FY 2022 · Dec 31, 2020 $15.1M
Net Income FY 2022 · Dec 31, 2022 −$57.19M
Net Income FY 2022 · Dec 31, 2021 −$49.45M
Net Income FY 2022 · Dec 31, 2020 −$69.48M
Operating Income FY 2022 · Dec 31, 2022 −$55.49M
Operating Income FY 2022 · Dec 31, 2021 −$48.53M
Operating Income FY 2022 · Dec 31, 2020 −$66.13M
Cost Of Revenue FY 2022 · Dec 31, 2022 $28.58M
Cost Of Revenue FY 2022 · Dec 31, 2021 $13.15M
Cost Of Revenue FY 2022 · Dec 31, 2020 $766K
Revenue FY 2022 · Dec 31, 2022 $36.94M
Revenue FY 2022 · Dec 31, 2021 $28.9M
Revenue FY 2022 · Dec 31, 2020 $5.03M
Short Term Investments FY 2022 · Dec 31, 2021 $16K